Your browser doesn't support javascript.
loading
Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in Japan.
Matsuyama, Hiroshi; Yamazaki, Keisuke; Okabe, Ryuichi; Ueki, Yushi; Shodo, Ryusuke; Omata, Jo; Sato, Yuichiro; Ota, Hisayuki; Takahashi, Takeshi; Tomita, Masahiko; Yokoyama, Yusuke; Togashi, Takafumi; Aoyama, Hidefumi; Abe, Eisuke; Saijo, Yasuo; Katsura, Kouji; Soga, Marie; Sugita, Tadashi; Matsumoto, Yasuo; Tsuchida, Emiko; Horii, Arata.
Affiliation
  • Matsuyama H; Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Electronic address: matsuhiroshi@med.niigata-u.ac.jp.
  • Yamazaki K; Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Okabe R; Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Ueki Y; Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Shodo R; Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Omata J; Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Sato Y; Department of Head and Neck Surgery, Niigata Cancer Center Hospital, Niigata, Japan.
  • Ota H; Department of Head and Neck Surgery, Niigata Cancer Center Hospital, Niigata, Japan.
  • Takahashi T; Department of Head and Neck Surgery, Niigata Cancer Center Hospital, Niigata, Japan.
  • Tomita M; Department of Otorhinolaryngology, Nagaoka Red Cross Hospital, Niigata, Japan.
  • Yokoyama Y; Department of Otorhinolaryngology, Nagaoka Red Cross Hospital, Niigata, Japan.
  • Togashi T; Department of Otorhinolaryngology, Niigata City General Hospital, Niigata, Japan.
  • Aoyama H; Departments of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Abe E; Departments of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Saijo Y; Departments of Medical Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Katsura K; Departments of Oral and Maxillofacial Radiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Soga M; Departments of Oral and Maxillofacial Radiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Sugita T; Department of Radiation Therapy, Niigata Cancer Center Hospital, Niigata, Japan.
  • Matsumoto Y; Department of Radiation Therapy, Niigata Cancer Center Hospital, Niigata, Japan.
  • Tsuchida E; Department of Radiation Oncology, Niigata City General Hospital, Niigata, Japan.
  • Horii A; Departments of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Auris Nasus Larynx ; 45(5): 1086-1092, 2018 Oct.
Article in En | MEDLINE | ID: mdl-29567334

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Chemoradiotherapy / Squamous Cell Carcinoma of Head and Neck / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Auris Nasus Larynx Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Chemoradiotherapy / Squamous Cell Carcinoma of Head and Neck / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Auris Nasus Larynx Year: 2018 Type: Article